Articles Vol. 67 No. 8 28/08/2026

ASSOCIATION BETWEEN MEDICATION ADHERENCE AND QUALITY OF LIFE AMONG OUTPATIENTS WITH TYPE 2 DIABETES

Chau Duc Tuyen1,2, Chau Duc Tuyen1,2, Nguyen Trong Nhan1,2
1 Vo Truong Toan University
2 Trường Đại học Võ Trường Toản
DOI: 10.52163/yhc.v67i8.6298
12 Views
0 Downloads
Keywords
Type 2 diabetes, medication adherence, quality of life, 15D instrument, outpatient care.
Abstract

Objective: To assess health-related quality of life and analyze the association between medication adherence and quality of life among outpatients with type 2 diabetes.

Subjects and methods: A cross-sectional descriptive study was conducted among 379 outpatients with type 2 diabetes. Quality of life was assessed using the 15D instrument, while medication adherence was measured using the 8-item Morisky Medication Adherence Scale. Diabetes self-care behaviors were evaluated using the Summary of Diabetes Self-Care Activities scale. Data were analyzed using SPSS version 22.0 with descriptive statistics and regression analyses.

Results: The mean 15D quality-of-life score was 0.9 ± 0.1 points. The lowest domain score was observed for sexual activity (0.3 ± 0.2 points), followed by vision (0.8 ± 0.2 points). Analyses showed that the likelihood of non-adherence decreased as overall quality-of-life scores and domains such as sleep, vitality, depression, and sexual activity improved (p < 0.05).

Conclusion: Overall quality of life among outpatients with type 2 diabetes in this study was relatively high. Medication adherence was associated with quality of life and diabetes self-care behaviors. Strengthening interventions to improve medication adherence may contribute to better quality of life and more effective diabetes management.

References
[1]
Wu C.H, Wong M.C, Wang H.H et al. The eight-item Morisky medication adherence scale (MMAS-8) score was associated with glycaemic control in diabetes patients. Diabetes, 2014, 64 (suppl 1): A558-A558. doi: 10.1002/jcph.408 Google Scholar
[2]
Hannula V, Hautala N, Sintonen H et al. Health-related quality of life using the 15D instrument of young adults with type 1 diabetes since childhood: population-based Oulu cohort study of diabetic retinopathy. Acta Ophthalmol, 2014, 92 (3): 205-208. doi: 10.1111/aos.12122. Google Scholar
[3]
Sintonen H. An approach to measuring and valuing health states. Soc Sci Med Med Econ, 1981, 15 (2): 55-65. doi: 10.1016/0160-7995(81)90019-8 Google Scholar
[4]
Lim J.T, Park J.H, Lee J.S et al. The relationship between the social network of community-living elders and their health-related quality of life in a Korean province. J Prev Med Public Health, 2013, 46 (1): 28-38. doi: 10.3961/jpmph.2013.46.1.28 Google Scholar
[5]
Dickerson F, Wohlheiter K, Medoff D et al. Predictors of quality of life in type 2 diabetes patients with schizophrenia, major mood disorder, and without mental illness. Qual Life Res, 2011, 20 (9): 1419-1425. doi: 10.1007/s11136-011-9888-5. Google Scholar
[6]
Saleh F, Ara F, Mumu S.J et al. Assessment of health-related quality of life of Bangladeshi patients with type 2 diabetes using the EQ-5D: a cross-sectional study. BMC Res Notes, 2015, 8: 497. doi: 10.1186/s13104-015-1453-9. Google Scholar
[7]
Siira H, Falck A, Kyngäs H. Health-related quality of life and related factors among older adults with visual impairments. Br J Vis Impair, 2019, 37 (2): 178-190. doi: 10.1177/0264619619839737 Google Scholar
[8]
Haapaniemi T.H, Sotaniemi K.A, Sintonen H et al. The generic 15D instrument is valid and feasible for measuring health-related quality of life in Parkinson’s disease. J Neurol Neurosurg Psychiatry, 2004, 75 (7): 976-983. doi: 10.1136/jnnp.2003.015693 Google Scholar
[9]
Okamoto N, Hisashige A, Tanaka Y et al. Development of the Japanese 15D instrument of health-related quality of life: verification of reliability and validity among elderly people. PLoS One, 2013, 8 (4): e61721. doi: 10.1371/journal.pone.0061721 Google Scholar
[10]
Cerkoney K.A, Hart L.K. The relationship between the health belief model and compliance of persons with diabetes mellitus. Diabetes Care, 1980, 3 (5): 594-598. doi: 10.2337/diacare.3.5.594 Google Scholar
[11]
Farhat R, Assaf J, Jabbour H et al. Adherence to oral glucose-lowering drugs, quality of life, treatment satisfaction and illness perception: a cross-sectional study in patients with type 2 diabetes. Saudi Pharm J, 2019, 27 (1): 126-132. doi: 10.1016/j.jsps.2018.09.005. Google Scholar
[12]
Zioga E, Kazakos K, Dimopoulos E et al. Adherence and quality of life in patients with type II diabetes mellitus in northern Greece. Mater Sociomed, 2016, 28 (4): 258-262. doi: 10.2337/diacare.3.5.594 Google Scholar
[13]
Alfian S.D, Sukandar H, Lestari K et al. Medication adherence contributes to an improved quality of life in type 2 diabetes mellitus patients: a cross-sectional study. Diabetes Ther, 2016, 7 (4): 755-764. doi: 10.1007/s13300-016-0203-x. Google Scholar